• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CO2-L; ENZYMATIC, CARBON-DIOXIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CO2-L; ENZYMATIC, CARBON-DIOXIDE Back to Search Results
Catalog Number 03289923190
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/27/2023
Event Type  malfunction  
Event Description
The initial reporter stated they received questionable results for four samples from the same patient tested with co2-l (bicarbonate) on a cobas 8000 cobas c 502 module.The results obtained for the patient did not fit the patient's diagnosis of acidosis.The first sample resulted in a bicarbonate value of 4 mmol/l on (b)(6) 2023.The second sample resulted in a bicarbonate value of 4 mmol/l on (b)(6) 2023.The third sample resulted in a bicarbonate value of 4 mmol/l on (b)(6) 2023.The fourth sample resulted in a bicarbonate value of 6.1 mmol/l on (b)(6) 2023.On an unknown date, a sample from the patient was tested on an unknown blood gas analyzer, resulting in the following values: ph = 7.35, paco2 = 49 (no units provided), pao2 = 88 (no units provided), bicarbonate = 26 mmol/l, lactate = 2.1 (no units provided).
 
Manufacturer Narrative
The serial number of the c 502 module is (b)(6).The last calibration performed on 18-oct-2023 was ok.Quality controls recovered within range.A general reagent issue can be ruled out as calibration and controls are acceptable.
 
Manufacturer Narrative
Protein electrophoresis was performed on a sample from the patient and a peak in the gamma globulin fraction was identified.Gammopathy of the patient cannot be excluded.A general reagent issue can be ruled out as calibration and controls are acceptable.The investigation determined that the issue is consistent with monoclonal gammopathy of the patient.The investigation could not identify a product problem.Per product labeling: "in very rare cases, gammopathy, in particular type igm (waldenström¿s macroglobulinemia), may cause unreliable results.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CO2-L
Type of Device
ENZYMATIC, CARBON-DIOXIDE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18194372
MDR Text Key328825593
Report Number1823260-2023-03753
Device Sequence Number1
Product Code KHS
UDI-Device Identifier04015630919352
UDI-Public04015630919352
Combination Product (y/n)Y
PMA/PMN Number
K031879
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03289923190
Device Lot Number71047401
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/30/2023
Initial Date FDA Received11/22/2023
Supplement Dates Manufacturer Received12/20/2023
Supplement Dates FDA Received01/12/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BISOPROLOL; COUMADIN; FUROSEMIDE; LEVOTHYROX; MACROFOL; SERESTA; TRIMEBUTIN; ZOPICLONE
Patient Age91 YR
Patient SexFemale
-
-